Iran war impacts global tech supply chain: European chip imports face obstacles, rising costs, and delivery delays
Golden Ten Data, March 19 — According to CNBC, industry insiders revealed that due to the impact of the Iran war, air transport routes passing through the Middle East have been disrupted. European chip importers are facing soaring costs and delivery delays—they are forced to use inventory and pay higher freight rates. Since the outbreak of the conflict on February 28, airports and shipping have been frequently attacked, causing chaos in cargo flight routes. Data from logistics company DSV shows that global air cargo capacity (mainly used for transporting high-value electronic products such as semiconductors) has dropped by about 9% compared to pre-war levels. DSV's air freight director, Kricken, said: "Inventory will continue to decline in the coming weeks, and everyone is hoping freight rates will return to normal." He pointed out that European car manufacturers are bearing the brunt, and although many buyers have not significantly reduced imports, they have started paying premiums to ensure delivery. An informed source revealed that some deliveries from a European chip company have been delayed by several days, air freight costs have risen, and the trend for the coming months is difficult to predict.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
